Sold our long positions in ERB and SENR In our 10/13/2014 call to action we stated we were initiating long positions in ERB and SENR due to other segments of the Ebola hype began to gain attention. We have now […]
Ocean Bio-Chem (OBCI) – If Falls Below $4.00, We are Buyers We will possibly look to add to our GeoBargain OBCI ($4.92) position if shares fall below $4.00. Ebola trades have certainly become more complicated as several reports are stating that […]
Ibio (AMEX:IBIO) Price Movement From Ebola/Enterovirus Hype Ibio (AMEX:IBIO) ($1.47) is a leading provider of plant-based biotechnology for developing and manufacturing biological products. As expected, the hype surrounding the Ebola and Enterorvirus outbreaks in the U.S. will inevitably led to aggressive share price […]
Looking for Long and Short Ebola Plays Due to the hype surrounding the Ebola and Enterovirus, we are now searching for related long and short ideas. So far, we focused our bullish Ebola calls on protective apparel and disinfectant themes. This […]
Locked in some gains in LAKE ($10.03) The GeoTeam has locked in some gains in its LAKE position. In our 9/15/2014 call to action we stated we were taking a speculative position in LAKE when the stock was trading at […]
Summary REPR’s flagship product has a firm grip on the growing infusion homecare market and REPR’s stock is trading at a significant discount to what it’s worth. The product is held in high regard by those in the industry, who […]
GeoTeam Looking to Trade Hemispherx Biopharma (HEB) ($0.35) on Chardan Update The Geoteam will look to trade HEB due to Chardan Capital pitching the company as an EBOLA play with a $3 price target. “Chardan Capital affirms its Buy rating […]
Summary We believe Stellar Biotechnologies’ (SBOTF) share price to be a product of a well timed promotional campaign. SBOTF’s share count has risen 88.2% in three short years and the September 2013 PIPE was done at a fully diluted share […]